REPORT ID 6576

EMEA (Europe, Middle East and Africa) Artificial Organs Market Report 2017

Publish Date
26-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the EMEA Artificial Organs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Artificial Organs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Artificial Organs market competition by top manufacturers/players, with Artificial Organs sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Diabetes Care, Inc.
    Abiomed, Inc. 
    Asahi Kasei Medical Co., Ltd.
    Baxter International, Inc.
    F.Hoffmann-La Roche Ltd. 
    Fresenius Medical Care AG & Co. KGaA 
    HeartWare International, Inc. 
    Jarvik Heart, Inc. 
    Medtronic, Inc. 
    Nikkiso Co., Ltd.
    Nipro Corporation 
    SynCardia Systems, Inc.
    Terumo Heart, Inc. 
    Thoratec Corp.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Artificial Heart
    Artificial Liver
    Artificial Pancreas
    Artificial Lungs
    Artificial Kidney
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Artificial Organs Market Report 2017
1 Artificial Organs Overview
    1.1 Product Overview and Scope of Artificial Organs
    1.2 Classification of Artificial Organs
        1.2.1 EMEA Artificial Organs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Artificial Organs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Artificial Heart
        1.2.4 Artificial Liver
        1.2.5 Artificial Pancreas
        1.2.6 Artificial Lungs
        1.2.7 Artificial Kidney
        1.2.8 Other
    1.3 EMEA Artificial Organs Market by Application/End Users
        1.3.1 EMEA Artificial Organs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 EMEA Artificial Organs Market by Region
        1.4.1 EMEA Artificial Organs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Artificial Organs (2012-2022)
        1.5.1 EMEA Artificial Organs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Artificial Organs Revenue and Growth Rate (2012-2022)

2 EMEA Artificial Organs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Artificial Organs Market Competition by Players/Manufacturers
        2.1.1 EMEA Artificial Organs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Artificial Organs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Artificial Organs Sale Price by Players (2012-2017)
    2.2 EMEA Artificial Organs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Artificial Organs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Artificial Organs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Artificial Organs Sale Price by Type (2012-2017)
    2.3 EMEA Artificial Organs (Volume) by Application
    2.4 EMEA Artificial Organs (Volume and Value) by Region
        2.4.1 EMEA Artificial Organs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Artificial Organs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Artificial Organs Sales Price by Region (2012-2017)

3 Europe Artificial Organs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Artificial Organs Sales and Value (2012-2017)
        3.1.1 Europe Artificial Organs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Artificial Organs Revenue and Growth Rate (2012-2017)
    3.2 Europe Artificial Organs Sales and Market Share by Type
    3.3 Europe Artificial Organs Sales and Market Share by Application
    3.4 Europe Artificial Organs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Artificial Organs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Artificial Organs Revenue by Countries (2012-2017)
        3.4.3 Germany Artificial Organs Sales and Growth Rate (2012-2017)
        3.4.4 France Artificial Organs Sales and Growth Rate (2012-2017)
        3.4.5 UK Artificial Organs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Artificial Organs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Artificial Organs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Artificial Organs Sales and Growth Rate (2012-2017)

4 Middle East Artificial Organs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Artificial Organs Sales and Value (2012-2017)
        4.1.1 Middle East Artificial Organs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Artificial Organs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Artificial Organs Sales and Market Share by Type
    4.3 Middle East Artificial Organs Sales and Market Share by Application
    4.4 Middle East Artificial Organs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Artificial Organs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Artificial Organs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Artificial Organs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Artificial Organs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Artificial Organs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Artificial Organs Sales and Growth Rate (2012-2017)

5 Africa Artificial Organs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Artificial Organs Sales and Value (2012-2017)
        5.1.1 Africa Artificial Organs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Artificial Organs Revenue and Growth Rate (2012-2017)
    5.2 Africa Artificial Organs Sales and Market Share by Type
    5.3 Africa Artificial Organs Sales and Market Share by Application
    5.4 Africa Artificial Organs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Artificial Organs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Artificial Organs Revenue by Countries (2012-2017)
        5.4.3 South Africa Artificial Organs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Artificial Organs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Artificial Organs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Artificial Organs Sales and Growth Rate (2012-2017)

6 EMEA Artificial Organs Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Diabetes Care, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Artificial Organs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Diabetes Care, Inc. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Abiomed, Inc. 
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Artificial Organs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Abiomed, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Asahi Kasei Medical Co., Ltd.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Artificial Organs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Asahi Kasei Medical Co., Ltd. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Baxter International, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Artificial Organs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Baxter International, Inc. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 F.Hoffmann-La Roche Ltd. 
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Artificial Organs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 F.Hoffmann-La Roche Ltd.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Fresenius Medical Care AG & Co. KGaA 
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Artificial Organs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Fresenius Medical Care AG & Co. KGaA  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 HeartWare International, Inc. 
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Artificial Organs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 HeartWare International, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Jarvik Heart, Inc. 
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Artificial Organs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Jarvik Heart, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Medtronic, Inc. 
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Artificial Organs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Medtronic, Inc.  Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Nikkiso Co., Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Artificial Organs Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Nikkiso Co., Ltd. Artificial Organs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Nipro Corporation 
    6.12 SynCardia Systems, Inc.
    6.13 Terumo Heart, Inc. 
    6.14 Thoratec Corp.

7 Artificial Organs Manufacturing Cost Analysis
    7.1 Artificial Organs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Artificial Organs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Artificial Organs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Artificial Organs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Artificial Organs Market Forecast (2017-2022)
    11.1 EMEA Artificial Organs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Artificial Organs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Artificial Organs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Artificial Organs Price and Trend Forecast (2017-2022)
    11.2 EMEA Artificial Organs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Artificial Organs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Artificial Organs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Artificial Organs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Artificial Organs Sales Forecast by Type (2017-2022)
    11.7 EMEA Artificial Organs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer